186 related articles for article (PubMed ID: 27738816)
21. DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma.
Blough MD; Al-Najjar M; Chesnelong C; Binding CE; Rogers AD; Luchman HA; Kelly JJ; Fliegel L; Morozova O; Yip S; Marra M; Weiss S; Chan JA; Cairncross JG
Ann Neurol; 2012 Jun; 71(6):845-9. PubMed ID: 22718548
[TBL] [Abstract][Full Text] [Related]
22. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
[TBL] [Abstract][Full Text] [Related]
23. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR
Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632
[TBL] [Abstract][Full Text] [Related]
24. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
Jentoft M; Giannini C; Rossi S; Mota R; Jenkins RB; Rodriguez FJ
Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
[TBL] [Abstract][Full Text] [Related]
25. Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion.
Nagaishi M; Suzuki A; Nobusawa S; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2014 Oct; 31(4):257-64. PubMed ID: 24197863
[TBL] [Abstract][Full Text] [Related]
26. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
27. IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
Miyake Y; Fujii K; Nakamaura T; Ikegaya N; Matsushita Y; Gobayashi Y; Iwashita H; Udaka N; Kumagai J; Murata H; Takemoto Y; Yamanaka S; Ichimura K; Tateishi K; Yamamoto T
J Neuropathol Exp Neurol; 2021 Feb; 80(3):247-253. PubMed ID: 33432322
[TBL] [Abstract][Full Text] [Related]
28. A case of oligodendroglioma with prominent neuronal differentiation.
Hirose T; Nobusawa S; Nakazato Y; Sasaki A
Hum Pathol; 2013 Oct; 44(10):2353-9. PubMed ID: 24054724
[TBL] [Abstract][Full Text] [Related]
29. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis identified genes associated with a favorable prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang Z; Li M; Jiang T
Genes Chromosomes Cancer; 2016 Feb; 55(2):169-76. PubMed ID: 26542540
[TBL] [Abstract][Full Text] [Related]
31. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
Burgy M; Chenard MP; Noël G; Bourahla K; Schott R
J Med Case Rep; 2019 Jun; 13(1):202. PubMed ID: 31248444
[TBL] [Abstract][Full Text] [Related]
32. Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts.
Lee J; Putnam AR; Chesier SH; Banerjee A; Raffel C; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Perry A; Solomon DA
Acta Neuropathol Commun; 2018 Sep; 6(1):95. PubMed ID: 30231927
[No Abstract] [Full Text] [Related]
33. Enchondromatosis-associated oligodendroglioma: case report and literature review.
Achiha T; Arita H; Kagawa N; Murase T; Ikeda JI; Morii E; Kanemura Y; Fujimoto Y; Kishima H
Brain Tumor Pathol; 2018 Jan; 35(1):36-40. PubMed ID: 29224049
[TBL] [Abstract][Full Text] [Related]
34. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.
Thirant C; Varlet P; Lipecka J; Le Gall M; Broussard C; Chafey P; Studler JM; Lacombe J; Lions S; Guillaudeau A; Camoin L; Daumas-Duport C; Junier MP; Chneiweiss H
Proteomics; 2011 Nov; 11(21):4139-54. PubMed ID: 21898821
[TBL] [Abstract][Full Text] [Related]
36. Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components.
Hattab EM; Martin SE; Shapiro SA; Cheng L
J Neurosurg; 2011 Jun; 114(6):1648-53. PubMed ID: 21214337
[TBL] [Abstract][Full Text] [Related]
37. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
[TBL] [Abstract][Full Text] [Related]
38. A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.
Gadji M; Crous-Tsanaclis AM; Mathieu D; Mai S; Fortin D; Drouin R
Neuropathology; 2014 Apr; 34(2):170-8. PubMed ID: 24118308
[TBL] [Abstract][Full Text] [Related]
39. A rare case of oligodendroglioma with gangliocytic differentiation in a 31-year-old male: importance of genetic testing for IDH1/2.
Park JH; Cha YJ; Chang JH; Lee SK; Kim SH
Brain Tumor Pathol; 2020 Jul; 37(3):95-99. PubMed ID: 32504153
[TBL] [Abstract][Full Text] [Related]
40. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB
J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]